Tag Archives: Point

Hey, naysayers: Bristol-Myers’ Celgene buy just chalked up another point in its favor

Bristol-Myers Squibb scored more bragging rights for its coming megamerger: The FDA is now officially reviewing one of the “Big 5” Celgene candidates touted as cornerstones of the deal. And it’s ozanimod, the blockbuster MS prospect whose application the FDA wouldn’t even consider last year. Regulators in both the U.S. and Europe accepted Celgene’s ozanimod filings to… Read More »

Health in 2 Point 00, Episode 71 | Livongo’s SIGNUM 2019, Bobblehead Edition!

Today on Health in 2 Point 00, Jess and I are at Livongo’s SIGNUM 2019 conference in San Francisco—in bobblehead form. In this episode, Jess asks me about my key takeaways from the conference, which focused on chronic condition solutions. It was really exciting to hear how the experience of patients with chronic conditions has… Read More »

Health in 2 Point 00, Episode 49

THCB FROM A-Z FOLLOW US ON TWITTER@THCBStaff WHERE IN THE WORLD WE ARE The Health Care Blog (THCB) is based in San Francisco. We were founded in 2003 by Matthew Holt. John Irvine joined in 2005 and ran the site for many years. MEDIA REQUESTS Interview Requests + Bookings. We like to talk. E-mail us.… Read More »